case report aspiration during anesthesia semaglutide 2023 Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk GLP-1 Medication Disclosure Before Anesthesia:

Larger and longer studies in broader populations are needed to fully understand the safety and efficacy in people with alcohol use disorder, but these initial findings are promising. In the research, published in the journal JAMA Psychiatry, 48 people with drinking problems were recruited, who had not been actively seeking treatment

Rising Adverse Events The FDA recently reported receiving serious adverse events linked to 'compounded semaglutide.' The specifics are yet to be disclosed but are expected to be released soon

2025;393:635647 (including supplement)

The GLP-1 antagonists then mimic the effects of the naturally-developed GLP-1

However, its important to note that these drugs themselves arent technically FDA-approved

Calorie Restriction and Nutrient Deficiencies GLP-1 medications suppress appetite, which can lead to lower protein intake and reduced absorption of micronutrients like iron , zinc , biotin , and B vitamins all of which are critical for healthy hair growth